Africa CDC mobilises 110 million dollars for Ebola response

    African nations increase domestic funding to combat outbreaks and reduce reliance on external aid.

    2 min read4 min listen

    African countries have mobilised approximately 110 million US dollars to support responses to Ebola and other disease outbreaks. Dr. Jean Kaseya, Director-General of the Africa Centres for Disease Control and Prevention (Africa CDC), announced this significant financial commitment. The funding aims to strengthen the continent's health security and reduce dependence on external funding sources.

    This mobilisation of resources comes as Ebola continues to claim lives in the Democratic Republic of Congo (DRC) and Uganda. The Africa CDC is actively leading clinical trials for therapeutics and preventive measures. A vaccine clinical trial is expected to begin next month, marking a crucial step in the fight against the deadly virus.

    The announcement was made at a press conference in Accra on Wednesday, July 24, 2026. This event took place on the sidelines of the African Union (AU) Extraordinary Summit on Health 2026. Ghana's President John Dramani Mahama convened the summit, gathering heads of state and health ministers. Their primary goal was to secure Africa’s “health sovereignty” amidst declining international donor funding.

    Dr. Kaseya emphasised the need for increased domestic resources. He stated, “We need more resources domestically so that we won’t go cup in hand begging from external sources.” This sentiment underscores a broader continental push for self-reliance in health matters. The Africa CDC boss also provided updates on the continent’s response to current Ebola outbreaks. He highlighted broader initiatives aimed at achieving health sovereignty across Africa.

    In a related development, the Africa CDC has formally requested the United States Secretary of State to lift travel restrictions imposed on Uganda. Dr. Kaseya clarified that this appeal is based on scientific evidence, not emotion. He noted Uganda's strong political commitment and significant progress in managing Ebola and other outbreaks, including Marburg virus disease. This demonstrates a data-driven approach to public health diplomacy.

    Dr. Kaseya commended African countries for increasingly financing their own emergency health responses. He expressed confidence that more resources would be mobilised to support ongoing interventions. The continent's push for health sovereignty aligns with the African Union’s broader vision of self-reliance. Discussions among African leaders and partners are focused on accelerating the implementation of this sovereignty agenda from 2027, particularly in the health sector.

    The Africa CDC Director-General expressed optimism that by December 2026, Africa would have significantly strengthened its preparedness against Ebola. This improvement would come through enhanced access to vaccines, therapeutics, and diagnostic tools. He stated, “We are doing our best to ensure that African countries can say by December 2026 that, thanks to a strong continental organisation, we will not be afraid of an Ebola outbreak because we have all the medical countermeasures.” This vision highlights a proactive strategy to mitigate future health crises.

    The increased domestic funding for health initiatives is a critical trend for Ghana and the wider African economy. It signals a shift towards greater fiscal responsibility and reduced reliance on foreign aid. This move could free up external funding for other developmental projects. It also strengthens regional economic stability by building resilient health systems. The ability to manage health crises internally reduces economic disruptions and protects human capital, which is vital for sustained growth.

    The commitment to health sovereignty will likely influence future budgetary allocations across African nations. Investors and international partners will observe how these domestic funding efforts translate into tangible health outcomes. The success of these initiatives could set a precedent for other sectors, encouraging greater self-sufficiency. The ongoing clinical trials and the target of strengthened preparedness by December 2026 are key milestones to watch.

    Comments

    More from StatsGH